Hi Rigormortis,
My view is that Covid totally changed the pathway for IVX, mainly due to lockdowns.
The lockdowns meant that human trials could not begin so they focused on developing INV043.
This reset the whole process and now the pathway to trials has been set out as per Ann.
- Forums
- ASX - By Stock
- Ann: Proposed issue of securities - IVX
IVX
invion limited
Add to My Watchlist
0.00%
!
13.5¢

Hi Rigormortis,My view is that Covid totally changed the pathway...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.43M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 13.5¢ | $4.833K | 35.80K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 24920 | 12.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.5¢ | 36360 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 24920 | 0.125 |
3 | 209200 | 0.120 |
3 | 377489 | 0.115 |
3 | 20320 | 0.105 |
5 | 65300 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.135 | 36360 | 4 |
0.140 | 37162 | 3 |
0.145 | 82000 | 2 |
0.150 | 146065 | 4 |
0.155 | 110008 | 2 |
Last trade - 13.25pm 18/06/2025 (20 minute delay) ? |
Featured News
IVX (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online